We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Future Not Looking Bright for Lilly's Strattera, Zyprexa
Future Not Looking Bright for Lilly's Strattera, Zyprexa
April 22, 2005
Eli Lilly reported decreased drug sales April 18, particularly for attention deficit disorder drug Strattera and schizophrenia treatment Zyprexa.